The presence of 19-kDa Bcl-2 in dividing cells

Cell Proliferation

Volumn 36, Issue 6, 2003, Pages 293-306

  Hoetelmans, R W M ^a,b   Van De Velde, C J H ^a   Van Dierendonck, J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Medical Information   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; GENE PRODUCT; NOCODAZOLE; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL DIVISION; CELL FRACTIONATION; CELL PROLIFERATION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENETIC TRANSFECTION; IMMUNOREACTIVITY; NONHUMAN; RAT;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL FRACTIONATION; CELL NUCLEUS; DOXORUBICIN; GENES, BCL-2; HUMANS; NOCODAZOLE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0344629222     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.2003.00286.x     Document Type: Article

References (40)

1. BLAGOSKLONNY MV, BISHOP PC, ROBEY R, FOJO T, BATES SE (2000) Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells. Cancer Res. 60, 3425.
2. BORNER C (1996) Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 271, 12695.
3. BRENNER C, CADIOU H, VIEIRA HL, ZAMZAMI N, MARZO I, XIE Z, LEBER B, ANDREWS D, DUCLOHIER H, REED JC, KROEMER G (2000) Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 19, 329.
4. BRICHESE L, BARBOULE N, HELIEZ C, VALETTE A (2002) Bcl-2 phosphorylation and proteasome-dependent degradation induced by paclitaxel treatment: consequences on sensitivity of isolated mitochondria to Bid. Exp. Cell Res. 278, 101.
5. CHENG EH, KIRSCH DG, CLEM RJ, RAVI R, KASTAN MB, BEDI A, UENO K, HARDWICK JM (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966.
6. CONSTANTINI P, BRUEY JM, CASTEDO M, METIVIER D, LOEFFLER M, SUSIN SA, RAVAGNAN L, ZAMZAMI N, GARRIDO C, KROEMER G (2002) Pre-processed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ. 9, 82.
7. DIMMELER S, BREITSCHOPF K, HAENDELER J, ZEIHER AM (1999) Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J. Exp. Med. 189, 1815.
8. ELLMAN GL (1959) Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82, 70.
9. FADEEL B, HASSAN Z, HELLSTROM-LINDBERG E, HENTER JI, ORRENIUS S, ZHIVOTOVSKY B (1999) Cleavage of Bcl-2 is an early event in chemotherapy- induced apoptosis of human myeloid leukemia cells. Leukemia 13, 719.
10. FORTNEY JE, HALL BM, BARTRUG L, GIBSON LF (2002) Chemotherapy induces bcl-2 cleavage in lymphoid leukemic cell lines. Leuk. Lymphoma 43, 2171.
11. FUJITA N, NAGAHASHI A, NAGASHIMA K, ROKUDAI S, TSURUO T (1998) Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene 17, 1295.
12. GRANDGIRARD D, STUDER E, MONNEY L, BELSER T, FELLAY I, BORNER C, MICHEL MR (1998) Alpha viruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. EMBO J. 17, 1268.
13. GUAN RJ, MOSS SF, ARBER N, KRAJEWSKI S, REED JC, HOLT PR (1996) 30-kDa phosphorylated form of Bcl-2 protein in human colon. Oncogene 12, 2605.
14. HALDAR S, JENA N, CROCE CM (1995) Inactivation of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA 92, 4507.
15. HIROTANI M, ZHANG Y, FUJITA N, NAITO M, TSURUO T (1999) NH2-terminal BH4 domain of Bcl-2 is functional for heterodimerization with Bax and inhibition of apoptosis. J. Biol. Chem. 274, 20415.
16. HOETELMANS RWM, VAN SLOOTEN HJ, KEIJZER R, ERKELAND S, VAN DE VELDE CJH, VAN DIERENDONCK JH (2000) Bcl-2 and Bax proteins are present in interphase nuclei of mammalian cells. Cell Death Differ. 7, 384.
17. HOETELMANS RWM, VAHRMEIJER AL, VAN VLIERBERGHE RLP, KEIJZER R., VAN DE VELDE CJH, MULDER GJ, VAN DIERENDONCK JH (2003a) The role of various Bcl-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain. Cell Prolif. 36, 35.
18. HOETELMANS RWM, VAHRMEIJER AL, MULDER GJ, VAN DE VELDE CJH, NAGELKERKE JF, VAN DIERENDONCK JH (2003b) Bcl-2 overexpression does not prevent but retards adriamycin toxicity in CC531 colon carcinoma cells. Chemotherapy in press.
19. HUANG DC, O'REILLY LA, STRASSER A, CORY S (1997) The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16, 4628.
20. KLUCK RM, BOSSY-WETZEL E, GREEN DR, NEWMEYER DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132.
21. KORSMEYER SJ (1999) Bcl-2 gene family and the regulation of programmed cell death. Cancer Res. 59, 1693.
22. KRAJEWSKI S, KRAJEWSKA M, ELLERBY LM, WELSH K, XIE Z, DEVERAUX QL, SALVESEN GS, BREDESEN DE, ROSENTHAL RE, FISKUM G, REED JC (1999) Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl Acad. Sci. USA 96, 5752.
23. LING YH, TORNOS C, PEREZ-SOLER R (1998) Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis. J. Biol. Chem. 273, 18984.
24. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ (1951) Protein measurement with the folin-phenol reagent. J. Biol. Chem. 193, 265.
25. MAY WS, TYLER PG, ITO T, ARMSTRONG DK, QATSHA KA, DAVIDSON NE (1994) Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2α in association with suppression of apoptosis. J. Biol. Chem. 269, 26865.
26. MAZEL S, BURTRUM D, PETRIE HT (1996) Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183, 2219.
27. MCDONNELL TJ, NUNEZ G, PLATT FM, HOCKENBERRY D, LONDON L, MCKEARN JP, KORSMEYER SJ (1990) Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell Biol. 10, 1901.
28. NAKAMURA H, NAKAMURA K, YODOI J (1997) Redox regulation of cellular activation. Annu. Rev. Immunol. 15, 351.
29. STENNICKE HR, DEVERAUX QL, HUMKE EW, REED JC, DIXIT VM, SALVESEN GS (1999) Caspase-9 can be activated without proteolytic processing. J. Biol. Chem. 274, 8359.
30. TSUJIMOTO Y, FINGER LR, YUNIS J, NOWELL PC, CROCE CM (1984) Cloning of the chromosome breakpoint of neoplastic B cells with the t (14; 18) chromosome translocation. Science 226, 1097.
31. VAUX DL, CORY S, ADAMS JM (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440.
32. VOEHRINGER DW, MCCONKEY DJ, MCDONNELL TJ, BRISBAY S, MEYN RE (1998) Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl Acad. Sci. USA 95, 2956.
33. WOOD DE, NEWCOMBE EW (2000) Cleavage of Bax enhances its cell death function. Exp. Cell Res. 256, 375.
34. WRIGHT SC, WANG H, WEI QS, KINDER DH, LARRICK JW (1998) Bcl-2-mediated resistance to apoptosis is associated with glutathione-induced inhibition of AP24 activation of nuclear DNA fragmentation. Cancer Res. 58, 5570.
35. XUE D, HORVITZ HR (1997) Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor. Nature 390, 305.
36. YAMAMOTO AM, ELOY L, BACH JF, GARCHON HJ (1998) N-terminus cleavage of bcl-2 by a novel cellular non-ICE cysteine proteinase. Leukemia 12, 1467.
37. ZEUNER A, ERAMO A, PESCHLE C, DE MARIA R (1999) Caspase activation without death. Cell Death Differ. 6, 1075.
38. ZHANG XM, LIN H, CHEN C, CHEN BD (1999) Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. Biochem. J. 340, 127.
39. ZHIVOTOVSKY B, SAMALI A, GAHM A, ORRENIUS S (1999) Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ. 6, 644.
40. ZOU H, LI Y, LIU X, WANG X (1999) An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274, 11549.